Replication-competent oncolytic herpes simplex viruses (HSVs) are considered a promising therapeutic approach for treatment of high-grade gliomas (HGGs), which are usually resistant to all the ...

Oncorus has raised $79.5 million to advance oncolytic viruses. The series B round equips Oncorus to move its lead prospect into the clinic and nominate an intravenously administered viral candidate ...

Flu cases are higher than usual for this time of year and are expected to soar in the coming weeks. Another virus, R.S.V., already is straining pediatric hospitals in some states. By Apoorva ...

When the coronavirus was spreading at its peak, it’s estimated that one infected individual could spread it to as many as three other people, who would spread it to three more, and those folks to ...

Four months ago, the phrase “R number” didn’t mean much to anyone except epidemiologists and infectious disease experts. But as the coronavirus pandemic has raced around the world, infecting millions ...